These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 33148374)
1. Punicalagin suppresses osteosarcoma growth and metastasis by regulating NF-κB signaling. Wang XZ; Zhang SF; Yang ZH; Ye ZW; Liu J J Biol Regul Homeost Agents; 2020; 34(5):1699-1708. PubMed ID: 33148374 [TBL] [Abstract][Full Text] [Related]
2. Punicalagin inhibited proliferation, invasion and angiogenesis of osteosarcoma through suppression of NF‑κB signaling. Huang T; Zhang X; Wang H Mol Med Rep; 2020 Sep; 22(3):2386-2394. PubMed ID: 32705250 [TBL] [Abstract][Full Text] [Related]
3. Sulforaphene inhibits the progression of osteosarcoma via regulating FSTL1/NF-κB pathway. Zhang G; Jin C; Zhu Y; Fu F; Wang G; Li S Life Sci; 2020 Dec; 263():118485. PubMed ID: 33017573 [TBL] [Abstract][Full Text] [Related]
4. Gambogenic acid suppresses bladder cancer cells growth and metastasis by regulating NF-κB signaling. Zhou S; Zhao N; Wang J Chem Biol Drug Des; 2020 Nov; 96(5):1272-1279. PubMed ID: 32491272 [TBL] [Abstract][Full Text] [Related]
5. Aspirin Suppresses the Growth and Metastasis of Osteosarcoma through the NF-κB Pathway. Liao D; Zhong L; Duan T; Zhang RH; Wang X; Wang G; Hu K; Lv X; Kang T Clin Cancer Res; 2015 Dec; 21(23):5349-59. PubMed ID: 26202947 [TBL] [Abstract][Full Text] [Related]
6. Baicalin Plays an Anti-Osteosarcoma Role Zhao ZF; Cheng XF; Yu M; Shi WF; Zhang T Discov Med; 2024 Aug; 36(187):1648-1656. PubMed ID: 39190380 [TBL] [Abstract][Full Text] [Related]
7. Amentoflavone Inhibits Metastatic Potential Through Suppression of ERK/NF-κB Activation in Osteosarcoma U2OS Cells. Pan PJ; Tsai JJ; Liu YC Anticancer Res; 2017 Sep; 37(9):4911-4918. PubMed ID: 28870912 [TBL] [Abstract][Full Text] [Related]
8. MiR-155 affects osteosarcoma cell proliferation and invasion through regulating NF-κB signaling pathway. Lu S; Liao QS; Tang L Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7633-7639. PubMed ID: 30536304 [TBL] [Abstract][Full Text] [Related]
9. LncRNA NKILA inhibits invasion and migration of osteosarcoma cells via NF-κB/Snail signaling pathway. Zhang GD; Li Y; Liao GJ; Qiu HW Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4118-4125. PubMed ID: 31173281 [TBL] [Abstract][Full Text] [Related]
10. Raddeanin A, a natural triterpenoid saponin compound, exerts anticancer effect on human osteosarcoma via the ROS/JNK and NF-κB signal pathway. Ma B; Zhu J; Zhao A; Zhang J; Wang Y; Zhang H; Zhang L; Zhang Q Toxicol Appl Pharmacol; 2018 Aug; 353():87-101. PubMed ID: 29847772 [TBL] [Abstract][Full Text] [Related]
11. Antitumor and anti-angiogenesis effects of thymoquinone on osteosarcoma through the NF-κB pathway. Peng L; Liu A; Shen Y; Xu HZ; Yang SZ; Ying XZ; Liao W; Liu HX; Lin ZQ; Chen QY; Cheng SW; Shen WD Oncol Rep; 2013 Feb; 29(2):571-8. PubMed ID: 23232982 [TBL] [Abstract][Full Text] [Related]
12. AMD3100 combined with triptolide inhibit proliferation, invasion and metastasis and induce apoptosis of human U2OS osteosarcoma cells. Jiang C; Fang X; Zhang H; Wang X; Li M; Jiang W; Tian F; Zhu L; Bian Z Biomed Pharmacother; 2017 Feb; 86():677-685. PubMed ID: 28038429 [TBL] [Abstract][Full Text] [Related]
13. Punicalagin induces senescent growth arrest in human papillary thyroid carcinoma BCPAP cells via NF-κB signaling pathway. Cheng X; Yao X; Xu S; Pan J; Yu H; Bao J; Guan H; Lu R; Zhang L Biomed Pharmacother; 2018 Jul; 103():490-498. PubMed ID: 29677534 [TBL] [Abstract][Full Text] [Related]
14. Theabrownin inhibits the cytoskeleton‑dependent cell cycle, migration and invasion of human osteosarcoma cells through NF‑κB pathway‑related mechanisms. Jin W; Gu C; Zhou L; Yang X; Gui M; Zhang J; Chen J; Dong X; Yuan Q; Shan L Oncol Rep; 2020 Dec; 44(6):2621-2633. PubMed ID: 33125106 [TBL] [Abstract][Full Text] [Related]
15. Destabilization of macrophage migration inhibitory factor by 4-IPP reduces NF-κB/P-TEFb complex-mediated c-Myb transcription to suppress osteosarcoma tumourigenesis. Zheng L; Feng Z; Tao S; Gao J; Lin Y; Wei X; Zheng B; Huang B; Zheng Z; Zhang X; Liu J; Shan Z; Chen Y; Chen J; Zhao F Clin Transl Med; 2022 Jan; 12(1):e652. PubMed ID: 35060345 [TBL] [Abstract][Full Text] [Related]
16. Visfatin promotes osteosarcoma cell migration and invasion via induction of epithelial-mesenchymal transition. Cheng G; Liu C; Sun X; Zhang L; Liu L; Ouyang J; Li B Oncol Rep; 2015 Aug; 34(2):987-94. PubMed ID: 26062797 [TBL] [Abstract][Full Text] [Related]
17. Ezrin/NF-κB Pathway Regulates EGF-induced Epithelial-Mesenchymal Transition (EMT), Metastasis, and Progression of Osteosarcoma. Liu P; Yang P; Zhang Z; Liu M; Hu S Med Sci Monit; 2018 Apr; 24():2098-2108. PubMed ID: 29628496 [TBL] [Abstract][Full Text] [Related]
18. Quercetin Inhibits Cell Migration and Invasion in Human Osteosarcoma Cells. Lan H; Hong W; Fan P; Qian D; Zhu J; Bai B Cell Physiol Biochem; 2017; 43(2):553-567. PubMed ID: 28965117 [TBL] [Abstract][Full Text] [Related]
19. Sorafenib Induces Apoptosis and Inhibits NF-κB-mediated Anti-apoptotic and Metastatic Potential in Osteosarcoma Cells. Wu CH; Lin KH; Fu BS; Hsu FT; Tsai JJ; Weng MC; Pan PJ Anticancer Res; 2021 Mar; 41(3):1251-1259. PubMed ID: 33788716 [TBL] [Abstract][Full Text] [Related]
20. High Expression of PKMYT1 Predicts Poor Prognosis and Aggravates the Progression of Osteosarcoma Lu Y; Li P; Zhou Y; Zhang J Curr Cancer Drug Targets; 2023; 23(6):496-504. PubMed ID: 36748214 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]